Abivax S.A.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 5 Aug 2026The company needs cash and is selling new shares at $125 per ADS, which dilutes existing owners slightly.
Preliminary filing shows the company preparing to raise money by selling new shares to the public.
Early investors are selling their shares; the company gets no money but pays registration costs.
Stocky reads Abivax S.A.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Abivax S.A.'s most recent tracked filing was a 424B5 on 2 Jul 2026: Raises $800 million selling 6.4 million shares.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 5 Aug 2026.